ArticleJournal of acquired immune deficiency syndromes (1999)2025

Initiation of Dolutegravir Versus Efavirenz on Viral Suppression and Retention at 6 months: A Regression Discontinuity Design.

Amy Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.